SEATTLE, WA–(Marketwired – May 16, 2017) – CFN Media Group (“CannabisFN”), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article taking a closer look at Harvest One Cannabis Inc.’s (TSX VENTURE: HVST) Satipharm AG subsidiary and its progress in commercializing its Gelpell CBD capsules. The article also discusses the company’s dual focus on developing both CBD and cannabis brands targeting Canada’s upcoming recreational cannabis and existing medical cannabis industries.
Emerging $3+ Billion Industry
The cannabis industry is booming thanks to the legalization of recreational marijuana across Canada and parts of the United States, but many consumers are looking for more than just a ‘high’ – they’re seeking the medical benefits of the plant.
While tetrahydrocannabinol (THC) has been widely studied for conditions like epilepsy, researchers are just starting to fully understand the benefits of cannabidiol (CBD). The lesser known non-psychoactive component of